Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 13,426 | 13,625 | 13,172 | 16,661 | 15,283 |
| Cost of Goods | 538 | 523 | 387 | 592 | 887 |
| Gross Profit | 12,888 | 13,102 | 12,785 | 16,069 | 14,396 |
| Operating Expenses | 13,637 | 13,571 | 13,243 | 13,457 | 12,508 |
| Operating Income | -749 | -469 | -458 | 2,612 | 1,888 |
| Interest Expense | 1,896 | 2,043 | 2,149 | 2,022 | 3,744 |
| Other Income | 797 | 769 | -1,489 | 669 | -21,688 |
| Pre-tax Income | -1,848 | -1,743 | -4,096 | 1,259 | -23,544 |
| Income Tax | 150 | -112 | -393 | 890 | -3,808 |
| Net Income Continuous | -1,998 | -1,631 | -3,703 | 369 | -19,736 |
| Net Income | $-1,998 | $-1,631 | $-3,703 | $369 | $-19,736 |
| EPS Basic Total Ops | -0.06 | -0.06 | -0.14 | 0.02 | -0.72 |
| EPS Basic Continuous Ops | -0.06 | -0.06 | -0.14 | 0.02 | -0.72 |
| EPS Diluted Total Ops | -0.06 | -0.06 | -0.14 | 0.02 | -0.72 |
| EPS Diluted Continuous Ops | -0.06 | -0.06 | -0.14 | 0.02 | -0.72 |
| EBITDA(a) | $8,183 | $8,403 | $6,171 | $11,323 | $-11,722 |